Matthew Korn

Matthew Korn is a Global Medical Affairs Director specializing in Radiopharmaceuticals, responsible for executing medical strategies for emerging compounds, including data generation and pre-launch activities. They have fourteen years of laboratory experience and have engaged with key academic centers and strategic alliances to support scientific exchange and transparency. Previously, Matthew served as a Senior MSL and Field Science Lead in Oncology at Bayer and held various research roles, including a postdoctoral fellowship at the University of California, Irvine, and a research fellowship in Neurology at the University of Michigan. Matthew earned a B.S. and a Ph.D. from the University of California, Irvine.